Toronto Dominion Bank
MIST icon

Toronto Dominion Bank’s Milestone Pharmaceuticals MIST Stock Holding History

Toronto Dominion Bank’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Hold
750,000
– – ﹤0.01% 1407
2026
Q1 		$893K Hold
750,000
– – ﹤0.01% 1351
2025
Q4 		$1.51M Hold
750,000
– – ﹤0.01% 1177
2025
Q3 		$1.5M Hold
750,000
– – ﹤0.01% 1115
2025
Q2 		$1.46M Hold
750,000
– – ﹤0.01% 1043
2025
Q1 		$600K Hold
750,000
– – ﹤0.01% 1133
2024
Q4 		$1.77M Buy
+750,000
New +$1.29M ﹤0.01% 950

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Toronto Dominion Bank's MIST Position: Q2 2026 in Review

Toronto Dominion Bank held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 750,000 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Toronto Dominion Bank first reported a position in MIST in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.77M in Q4 2024. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Toronto Dominion Bank held 750,000 shares of Milestone Pharmaceuticals worth $1M as of Q2 2026.
  • Toronto Dominion Bank left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1407 holding.
  • Toronto Dominion Bank first reported a position in Milestone Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Toronto Dominion Bank's Milestone Pharmaceuticals position peaked at $1.77M in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.